Microneedling: Know Before You Go

Microneedling is a minimally-invasive procedure that regenerates skin by stimulating the production of new collagen and elastin. The entire process takes about 15 minutes and the result is smoother, firmer, more even-looking skin.

SkinPen® Precision is the ONLY Class II, FDA Cleared Microneedling Device in the U.S.

Microneedling is trending, and for good reason. Everyone is falling in love with the results! It’s clinically proven safe, minimally invasive with little to no downtime, and helps improve the appearance acne scars. The outcome is beautiful, youthful looking skin. Read our full press release here.

Ask questions to protect your skin and your health

When done properly, microneedling is relatively risk-free and produces results with little to no downtime. The safest, most effective microneedling devices use sterile, disposable needle cartridges that reduce the risk of cross-contamination.

 SkinPen FDA approved | microneedling know before you go
Ask Questions about microneedling

The key to a safe procedure with great results is to find a practice that has your safety in mind. When you schedule an appointment ask questions like, “What microneedling device do you use?” and “Does your device have a disposable tip to protect from cross-contamination?”  If they can’t answer these questions, then consider finding another practice.

What’s the risk of cross-contamination?

The risk, as noted by the FDA, is that pathogenic contaminants can enter the cartridge after a treatment and pose a risk of cross-contamination. As with any procedure, patients should take precaution when determining whether the procedure and practices is right for them.

Bellus Medical Puts Safety First

Joe Proctor, President and CEO discusses Bellus Medical’s commitment to safety and quality.

If you have concerns, the FDA urges both healthcare professionals and patients to report these devices and any side effects to the FDA’s MedWatch Adverse Event Reporting program: https://www.accessdata.fda.gov/scripts/medwatch/index.cfm?action=reporting.home

 

SkinPen-CTA

2018-03-13T18:37:17+00:00